Drug Type CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism BCMA modulators(B-cell maturation protein modulators), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Phase 3 | China | 19 Oct 2017 | |
Purpura, Thrombocytopenic, Idiopathic | Phase 2 | China | 01 Jan 2022 |